宫颈癌生物芯片，75例，150芯（1.1mm），系列2
- CR-XCXC1502
- 科博瑞生物
- 湖北省武汉市
- 现货
- 张
- 议价
- 2024-07-02 10:39:31
科博瑞（武汉）生物科技有限公司
一键申请试用
咨询
加入意向单
联系方式
宫颈癌生物芯片，75例，150芯（1.1mm），系列2
宫颈癌组织芯片，系列2，不与CXC1501或CXC1503重复，75例，150芯，包括正常/良性（5例）和癌（70例)组织，双芯布阵。
提供病理分级和TNM分期数据。
货号：CR-XCXC1502
| 位置 | 年龄 | 性别 | 标本部位 | 病理分类 | 病理分级 | TNM_T | TNM_N | TNM_M |
| A1,B1 | 45 | F | 宫颈 | 正常 | ||||
| A2,B2 | 40 | F | 宫颈 | 正常 | ||||
| A3,B3 | 51 | F | 宫颈 | 正常 | ||||
| A4,B4 | 29 | F | 宫颈 | 息肉 | ||||
| A5,B5 | 40 | F | 宫颈 | 息肉 | ||||
| A6,B6 | 52 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| A7,B7 | 27 | F | 宫颈 | 腺鳞癌 | T2 | N1 | M0 | |
| A8,B8 | 40 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| A9,B9 | 33 | F | 宫颈 | 腺鳞癌 | T2 | N0 | M0 | |
| A10,B10 | 45 | F | 宫颈 | 鳞癌 | II~III | T1 | N0 | M0 |
| A11,B11 | 55 | F | 宫颈 | 鳞癌 | II~III | T2 | N1 | M0 |
| A12,B12 | 35 | F | 宫颈 | 鳞癌 | III | T2 | N1 | M0 |
| A13,B13 | 47 | F | 宫颈 | 鳞癌 | I | T2 | N0 | M0 |
| A14,B14 | 47 | F | 宫颈 | 腺鳞癌 | T1 | N0 | M0 | |
| A15,B15 | 57 | F | 宫颈 | 鳞癌 | II | T1 | N0 | M0 |
| C1,D1 | 44 | F | 宫颈 | 鳞癌 | II | T1 | N0 | M0 |
| C2,D2 | 47 | F | 宫颈 | 鳞癌 | II | T4 | N1 | M0 |
| C3,D3 | 67 | F | 宫颈 | 鳞癌 | III | T1 | N1 | M0 |
| C4,D4 | 39 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| C5,D5 | 30 | F | 宫颈 | 鳞癌 | III | T1 | N1 | M0 |
| C6,D6 | 56 | F | 宫颈 | 鳞癌 | II | T1 | N0 | M0 |
| C7,D7 | 41 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| C8,D8 | 51 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| C9,D9 | 68 | F | 宫颈 | 鳞癌 | III | T1 | N1 | M0 |
| C10,D10 | 30 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| C11,D11 | 46 | F | 宫颈 | 腺癌 | II~III | T1 | N0 | M0 |
| C12,D12 | 50 | F | 宫颈 | 鳞癌 | II | T1 | N0 | M0 |
| C13,D13 | 35 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| C14,D14 | 43 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| C15,D15 | 49 | F | 宫颈 | 鳞癌 | III | T2 | N1 | M0 |
| E1,F1 | 45 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| E2,F2 | 41 | F | 宫颈 | 鳞癌 | II~III | T1 | N0 | M0 |
| E3,F3 | 41 | F | 宫颈 | 鳞癌 | III | T1 | N1 | M0 |
| E4,F4 | 57 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| E5,F5 | 44 | F | 宫颈 | 鳞癌 | II~III | T1 | N0 | M0 |
| E6,F6 | 42 | F | 宫颈 | 鳞癌 | II~III | T1 | N1 | M0 |
| E7,F7 | 50 | F | 宫颈 | 腺癌 | II | T1 | N0 | M0 |
| E8,F8 | 45 | F | 宫颈 | 鳞癌 | III | T2 | N1 | M0 |
| E9,F9 | 54 | F | 宫颈 | 鳞癌 | II | T1 | N0 | M0 |
| E10,F10 | 42 | F | 宫颈 | 粘液腺癌 | T2 | N1 | M0 | |
| E11,F11 | 36 | F | 宫颈 | 鳞癌 | I | T1 | N0 | M0 |
| E12,F12 | 44 | F | 宫颈 | 鳞癌 | II~III | T1 | N0 | M0 |
| E13,F13 | 47 | F | 宫颈 | 鳞癌 | II~III | T1 | N1 | M0 |
| E14,F14 | 41 | F | 宫颈 | 鳞癌 | II~III | T1 | N0 | M0 |
| E15,F15 | 50 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| G1,H1 | 34 | F | 宫颈 | 腺鳞癌 | T1 | N0 | M0 | |
| G2,H2 | 46 | F | 宫颈 | 鳞癌 | III | T1 | N1 | M0 |
| G3,H3 | 58 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| G4,H4 | 40 | F | 宫颈 | 腺癌 | I~II | T1 | N0 | M0 |
| G5,H5 | 38 | F | 宫颈 | 腺癌 | II~III | T1 | N0 | M0 |
| G6,H6 | 46 | F | 宫颈 | 鳞癌 | III | T1 | N1 | M0 |
| G7,H7 | 48 | F | 宫颈 | 腺癌 | II | T1 | N0 | M0 |
| G8,H8 | 56 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| G9,H9 | 46 | F | 宫颈 | 鳞癌 | II | T1 | N0 | M0 |
| G10,H10 | 30 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| G11,H11 | 56 | F | 宫颈 | 未分化癌 | T1 | N1 | M0 | |
| G12,H12 | 60 | F | 宫颈 | 鳞癌 | III | T1 | N1 | M0 |
| G13,H13 | 40 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| G14,H14 | 54 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| G15,H15 | 51 | F | 宫颈 | 鳞癌 | I~II | T1 | N0 | M0 |
| I1,J1 | 36 | F | 宫颈 | 鳞癌 | II~III | T1 | N1 | M0 |
| I2,J2 | 40 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| I3,J3 | 65 | F | 宫颈 | 鳞癌 | II~III | T1 | N0 | M0 |
| I4,J4 | 51 | F | 宫颈 | 鳞癌 | I | T1 | N0 | M0 |
| I5,J5 | 37 | F | 宫颈 | 鳞癌 | II | T1 | N1 | M0 |
| I6,J6 | 41 | F | 宫颈 | 腺鳞癌 | T1 | N0 | M0 | |
| I7,J7 | 57 | F | 宫颈 | 鳞癌 | II~III | T1 | N1 | M0 |
| I8,J8 | 43 | F | 宫颈 | 鳞癌 | II | T1 | N0 | M0 |
| I9,J9 | 48 | F | 宫颈 | 鳞癌 | II~III | T1 | N0 | M0 |
| I10,J10 | 36 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| I11,J11 | 41 | F | 宫颈 | 鳞癌 | II~III | T2 | N0 | M0 |
| I12,J12 | 46 | F | 宫颈 | 腺癌 | II~III | T1 | N1 | M0 |
| I13,J13 | 40 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| I14,J14 | 34 | F | 宫颈 | 鳞癌 | III | T1 | N0 | M0 |
| I15,J15 | 63 | F | 宫颈 | 鳞癌 | II | T1 | N0 | M0 |
